Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial.
García-Alfonso P, Elez E, Soto-Alsar J, Páez D, Fernández-Montes A, Graña B, Salud A, Yubero A, Gómez-España MA, Macías I, Quintero G, López-López C, Fernández-Rodríguez T, Grávalos C, González-Flores E, Guix M, García Paredes B, Reina JJ, Rodríguez Mowbray JR, Sastre J, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD).
García-Alfonso P, et al. Among authors: reina jj.
ESMO Open. 2024 Dec;9(12):103986. doi: 10.1016/j.esmoop.2024.103986. Epub 2024 Nov 27.
ESMO Open. 2024.
PMID: 39608305
Free PMC article.
Clinical Trial.